These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2304356)

  • 21. High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival.
    Sagaster V; Ohler L; Berer A; Kabrna E; Ofner P; Lechner K; Geissler K
    Ann Hematol; 2004 Jan; 83(1):9-13. PubMed ID: 13680175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effects of IL-2 on NK-activity, clonogenic potential, blast cell proliferation and cytokine release of MDS bone marrow patients.
    Cortelezzi A; Sarina B; Cattaneo C; Pomati M; Silvestris I; Soligo D; Calori R; Di Stefano M; Hu C; Monza M; Radelli L; Maiolo AT
    Leukemia; 1996 Jul; 10(7):1181-9. PubMed ID: 8684000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes.
    Piacibello W; Sanavio F; Bresso P; Severino A; Carlesso N; Pregno P; Stacchini A; Morelli S; Fubini L; Gallo E
    Leukemia; 1994 Feb; 8(2):250-7. PubMed ID: 7508532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in number of bone marrow macrophages in patients with myelodysplastic syndromes.
    Kitagawa M; Kamiyama R; Kasuga T
    Eur J Haematol; 1993 Jul; 51(1):56-8. PubMed ID: 8348949
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of culture conditions on in vitro erythroid colony formation in myelodysplastic syndromes.
    Juvonen E; Ruutu T
    Exp Hematol; 1990 Nov; 18(10):1070-2. PubMed ID: 2209760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow cultures in dysmyelopoietic syndrome: diagnostic and prognostic evaluation.
    Shihab-el-Deen A; Guevara C; Prchal JF
    Acta Haematol; 1987; 78(1):17-22. PubMed ID: 3116803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of in vitro characteristics of colony-forming cells in myelodysplastic syndrome and comparison with that in non-severe aplastic anemia].
    Zhang TJ; Feng M; Zheng YZ; Li XX; Xu ZF; Qin TJ; Zhang Y; Yang YB; Liu JX; Ren YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):516-21. PubMed ID: 22967409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amifostine does not preferentially stimulate the growth of residual polyclonal progenitor cells in myelodysplastic syndromes.
    Delforge M; Raets V; Van Duppen V; Boogaerts M
    Leuk Res; 2003 Jul; 27(7):593-8. PubMed ID: 12681358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome.
    Shih LY; Chiu WF; Lee CT
    Leukemia; 1991 Dec; 5(12):1092-8. PubMed ID: 1774958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
    Merchav S; Wagemaker G; Souza LM; Tatarsky I
    Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of cytosine arabinoside on CFU-GM from patients with myelodysplastic syndrome.
    Bailey-Wood R; Clark RE; Dallimore CM; Jacobs A
    Clin Lab Haematol; 1987; 9(1):23-6. PubMed ID: 3581713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-lineage hemopoietic precursor cells and effectiveness of recombinant human erythropoietin in patients with myelodysplastic syndromes.
    Fukushima Y; Kanno Y; Miura AB
    Tohoku J Exp Med; 1992 Mar; 166(3):375-85. PubMed ID: 1585347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological and clinical significance of clonogenic assays in patients with myelodysplastic syndromes.
    Marisavljević D; Rolović Z; Sefer D; Basara N; Ilić D; Bosković D; Colović M
    Med Oncol; 2002; 19(4):249-59. PubMed ID: 12512919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-6 and interleukin-1 enhancement of GM-CSF-dependent proliferation of haematopoietic progenitor cells in myelodysplastic syndromes.
    Schipperus MR; Sonneveld P; Lindemans J; van Lom K; Vlastuin M; Abels J
    Br J Haematol; 1991 Apr; 77(4):515-22. PubMed ID: 2025577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease.
    Martínez-Jaramillo G; Gómez-Morales E; Sánchez-Valle E; Mayani H
    J Hematother Stem Cell Res; 2001 Jun; 10(3):347-54. PubMed ID: 11454310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
    Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
    Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implication and characterization of the blast cell population in the myelodysplastic syndrome.
    Goasguen JE; Bennett JM; Cox C; Hambley H; Mufti G; Flandrin G
    Leuk Res; 1991; 15(12):1159-65. PubMed ID: 1766264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro growth of bone marrow-derived multipotent and lineage-restricted hematopoietic progenitor cells in myelodysplastic syndromes.
    Carlo-Stella C; Cazzola M; Bernasconi P; Bergamaschi G; Dezza L; Pedrazzoli P; Rosti V; Tomaselli S; Zappone E
    Haematologica; 1989; 74(2):181-6. PubMed ID: 2501171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biology and clinical aspects of primary myelodysplastic syndromes].
    Urbańska-Ryś H; Robak T; Krykowski E
    Pol Tyg Lek; 1988 Feb; 43(7):225-9. PubMed ID: 3043403
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.